Drug Detail:Adenovirus vaccine (monograph) (Medically reviewed)
Drug Class:
Usual Adult Dose for Vaccination
One dose of 2 tablets (1 of Adenovirus Type 4 and 1 of Adenovirus Type 7), orally
Comments:
- Tablets should be swallowed whole, without chewing, to avoid releasing the virus in the upper respiratory tract.
- Postpone for vomiting and/or diarrhea; vaccine effectiveness depends upon viral multiplication within the intestinal tract.
Use: Active immunization for the prevention of febrile acute respiratory disease caused by Adenovirus Type 4 and Type 7, in military populations 17 through 50 years of age.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dialysis
Data not available
Other Comments
Administration advice:
- Tablets should be swallowed whole, without chewing, to avoid releasing the virus in the upper respiratory tract.
- Postpone for vomiting and/or diarrhea; vaccine effectiveness depends upon viral multiplication within the intestinal tract.
Storage requirements:
- Refrigerate; do not freeze
- Keep bottle tightly closed
- Protect from moisture; do not remove desiccant canister from bottle
Patient advice:
- Adenovirus is shed in the stool for 28 days following vaccination and can cause disease if transmitted.
- To minimize transmission risk, observe proper personal hygiene, such as frequent hand washing, especially after bowel movements.
- Use caution when in contact with children under 7 years old, immunocompromised people (e.g. people with HIV or cancer), and pregnant women for 28 days after vaccination.
- Women should avoid becoming pregnant for at least 6 weeks after vaccination to prevent fetal exposure to the virus.
